Combined OX40 Agonist and PD-1 Inhibitor Immunotherapy Improves the Efficacy of Vascular Targeted Photodynamic Therapy in a Urothelial Tumor Model.
Alvim RG, Georgala P, Nogueira L, Somma AJ, Nagar K, Thomas J, Alvim L, Riegel A, Hughes C, Chen J, Reis AB, Lebdai S, Scherz A, Zanganeh S, Gardner R, Kim K, Coleman JA.
Alvim RG, et al. Among authors: nogueira l.
Molecules. 2021 Jun 19;26(12):3744. doi: 10.3390/molecules26123744.
Molecules. 2021.
PMID: 34205347
Free PMC article.